<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03967197</url>
  </required_header>
  <id_info>
    <org_study_id>2020-8355</org_study_id>
    <nct_id>NCT03967197</nct_id>
  </id_info>
  <brief_title>Lidocaine Before Esophageal Manometry and Ambulatory pH Monitoring</brief_title>
  <official_title>Is Lidocaine Useful Before Esophageal Manometry and Ambulatory pH Monitoring? A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized controlled trial comparing esophageal manometry and ambulatory pH monitoring&#xD;
      test tolerance in the presence versus in the absence of topical lidocaine.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Conventionally, topical nasopharyngeal anesthesia is applied to improve the tolerance of&#xD;
      esophageal manometry and ambulatory pH monitoring. However, there is currently no data to&#xD;
      support this practice. This randomized controlled trial of lidocaine versus placebo applied&#xD;
      before these tests will evaluate the benefit of topical lidocaine anesthesia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 6, 2019</start_date>
  <completion_date type="Actual">August 5, 2020</completion_date>
  <primary_completion_date type="Actual">August 5, 2020</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of pain during catheter insertion</measure>
    <time_frame>Assessed once immediately after exam on patient questionnaire</time_frame>
    <description>As reported by patients on a standardized questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Global patient satisfaction</measure>
    <time_frame>Assessed once immediately after exam on patient questionnaire</time_frame>
    <description>As reported by patients on a standardized questionnaire (on scale of 1 to 5, 5 being highest satisfaction score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of other complications during catheter insertion</measure>
    <time_frame>Assessed once immediately after exam on patient questionnaire</time_frame>
    <description>As reported by patients on a standardized questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of complications during test recording</measure>
    <time_frame>Assessed once immediately after exam on patient questionnaire</time_frame>
    <description>As reported by patients on a standardized questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">304</enrollment>
  <condition>Pain, Acute</condition>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to the lidocaine intervention will receive 2 sprays of lidocaine hydrochloride 10% in each nostril 3-5 minutes before their test.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo (Saline)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients randomized to placebo will receive 2 sprays of physiological saline in each nostril 3-5 minutes before their test.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline spray</intervention_name>
    <description>Physiologic saline spray</description>
    <arm_group_label>Placebo (Saline)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Hydrochloride</intervention_name>
    <description>Lidocaine hydrochloride 10% spray</description>
    <arm_group_label>Lidocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Adult patients undergoing esophageal manometry or ambulatory pH monitoring at our center&#xD;
        who are able to read and consent to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients &lt; 18 years&#xD;
&#xD;
          -  Incapacity to provide consent&#xD;
&#xD;
          -  History of lidocaine allergy&#xD;
&#xD;
          -  Current pregnancy&#xD;
&#xD;
          -  Previous esophageal manometry or ambulatory pH monitoring in the last 14 days&#xD;
&#xD;
          -  Previous participation in the study&#xD;
&#xD;
          -  Severe cirrhosis (Child-Pugh C)&#xD;
&#xD;
          -  Severe chronic kidney disease (eGFR&lt;30 mL/min/1.73m2)&#xD;
&#xD;
          -  Severe heart failure (New York Heart Association Functional Classification 3-4)&#xD;
&#xD;
          -  Severe respiratory failure (dyspnea or oxygen-dependent at rest)&#xD;
&#xD;
          -  Any active severe incapacitating chronic or acute medical disease&#xD;
&#xD;
          -  Active hospitalization&#xD;
&#xD;
          -  Ulcerated, atrophic, infected or recently burned (in the last 30 days) nasopharynx&#xD;
&#xD;
          -  Recent surgery involving the nasopharynx (in the last 30 days)&#xD;
&#xD;
          -  Severe chronic pain (ex. regular daily use of opioids)&#xD;
&#xD;
          -  Previous stroke or any neurological lesion with resulting current sensory deficit&#xD;
&#xD;
          -  Major neurocognitive disorder&#xD;
&#xD;
          -  Any active severe incapacitating chronic or acute psychiatric disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre hospitalier de l'Université de Montréal</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 9, 2019</study_first_submitted>
  <study_first_submitted_qc>May 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2019</study_first_posted>
  <last_update_submitted>August 11, 2020</last_update_submitted>
  <last_update_submitted_qc>August 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>manometry</keyword>
  <keyword>pH monitoring</keyword>
  <keyword>lidocaine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

